JP Morgan Cautions Trade Tensions Are Weighing On Eastman Chemical Growth Prospects
The downgrade and lowered forecasts indicate reduced confidence and earnings risk for EMN.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The downgrade and lowered forecasts indicate reduced confidence and earnings risk for EMN.
What happened, with direct paths to the underlying reporting
JP Morgan downgraded EMN from Overweight to Neutral, lowering forecast to $76. First-quarter EPS of $1.91 beat estimates, but sales were below expectations. EMN anticipates Q2 EPS of $1.70-$1.90, below consensus of $2.18. U.S.-China tariffs and maintenance will negatively impact Q2 earnings. Analyst cuts 2025 EPS estimate to $7.40 from $8.45 amid trade uncertainties.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.